HK1119569A1 - Lipidated tissue factor for use as topical antihemorrhagic agent - Google Patents
Lipidated tissue factor for use as topical antihemorrhagic agentInfo
- Publication number
- HK1119569A1 HK1119569A1 HK08111596.7A HK08111596A HK1119569A1 HK 1119569 A1 HK1119569 A1 HK 1119569A1 HK 08111596 A HK08111596 A HK 08111596A HK 1119569 A1 HK1119569 A1 HK 1119569A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tissue factor
- lipidated tissue
- antihemorrhagic agent
- topical
- topical antihemorrhagic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05380179A EP1749536A1 (fr) | 2005-08-03 | 2005-08-03 | Stimulateurs activés du Facteur X et leur utilisation en tant qu'agents anti-hemorragiques pour l'usage topique |
PCT/EP2006/007660 WO2007014771A1 (fr) | 2005-08-03 | 2006-08-02 | Stimulateurs de facteur x active (fxa) utilises en tant que nouveaux agents antihemorragiques topiques |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1119569A1 true HK1119569A1 (en) | 2009-03-13 |
Family
ID=35916272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08111596.7A HK1119569A1 (en) | 2005-08-03 | 2008-10-21 | Lipidated tissue factor for use as topical antihemorrhagic agent |
Country Status (13)
Country | Link |
---|---|
EP (3) | EP1749536A1 (fr) |
JP (2) | JP2009503009A (fr) |
KR (1) | KR101362993B1 (fr) |
CN (1) | CN101291686B (fr) |
AU (1) | AU2006274979B2 (fr) |
BR (1) | BRPI0616535B8 (fr) |
CA (1) | CA2617534C (fr) |
DK (1) | DK1917026T3 (fr) |
ES (1) | ES2468225T3 (fr) |
HK (1) | HK1119569A1 (fr) |
PL (1) | PL1917026T3 (fr) |
TW (2) | TWI441645B (fr) |
WO (2) | WO2007014771A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772371B2 (en) * | 2005-08-03 | 2010-08-10 | Thrombotargets Corporation | Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents |
EP2745852A1 (fr) * | 2012-12-21 | 2014-06-25 | Thrombotargets Europe, S.L. | Compositions d'agent d'étanchéité |
EP2759305A1 (fr) * | 2013-01-24 | 2014-07-30 | Thrombotargets Europe, S.L. | Compositions hémostatiques |
CN110133303B (zh) * | 2019-05-13 | 2023-04-07 | 深圳优迪生物技术有限公司 | 凝血酶原时间测定试剂及其应用 |
CN112433057B (zh) * | 2020-11-10 | 2023-06-09 | 北京美创新跃医疗器械有限公司 | 一种狼疮抗凝物的筛选试剂及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721618A (en) * | 1983-06-27 | 1988-01-26 | Queen's University At Kingston | Method for controlling bleeding |
US5017556A (en) * | 1986-11-04 | 1991-05-21 | Genentech, Inc. | Treatment of bleeding disorders using lipid-free tissue factor protein |
EP0266993B1 (fr) * | 1986-11-04 | 1995-04-05 | Genentech, Inc. | Méthode et compositions thérapeutiques pour le traitement de désordres de la coagulation |
US6239101B1 (en) * | 1989-07-05 | 2001-05-29 | Oklahoma Medical Research Foundation | Thrombin binding polypeptides |
US6238875B1 (en) * | 1991-03-12 | 2001-05-29 | The Scripps Research Institute | Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1 |
WO1993009804A1 (fr) * | 1991-11-18 | 1993-05-27 | The Scripps Research Institute | Polypeptides derives de la serine protease et anticorps anti-peptidiques, systemes et procedes therapeutiques empechant la coagulation du sang |
AU4784693A (en) * | 1992-07-24 | 1994-02-14 | Oklahoma Medical Research Foundation | Blockade of protein c activation reduces microvascular surgical blood loss |
US5441759A (en) * | 1992-09-03 | 1995-08-15 | Sherwood Medical Company | Method to stabilize TDMAC heparin coating |
DK0833911T3 (da) * | 1995-06-07 | 2004-08-30 | Ortho Mcneil Pharm Inc | CDR-transplanterede anti-vævsfaktorantistoffer og fremgangsmåder til anvendelse deraf |
CA2335274A1 (fr) * | 1998-07-15 | 2000-01-27 | Genentech, Inc. | Variantes de proteines de facteurs tissulaires presentant une affinite accrue pour le facteur de coagulation fvii/fviia |
AU1458500A (en) * | 1998-10-30 | 2000-05-22 | Jonathan L. Miller | Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein IB alpha |
WO2002030479A1 (fr) * | 2000-10-13 | 2002-04-18 | On Site Gas Systems, Inc. | Bandage utilisant des tamis moleculaires |
US7015193B2 (en) * | 2001-04-20 | 2006-03-21 | University Of Vermont | Compositions and methods to control bleeding |
TWI338009B (en) * | 2001-10-29 | 2011-03-01 | Genentech Inc | Antibodies for inhibiting blood coagulation and methods of use thereof |
WO2004039842A2 (fr) * | 2002-10-31 | 2004-05-13 | Novo Nordisk A/S | Anticorps humanises anti-facteur tissulaire |
AU2005260004A1 (en) * | 2004-06-25 | 2006-01-12 | Altor Bioscience Corporation | Production of tissue factor in plants |
-
2005
- 2005-08-03 EP EP05380179A patent/EP1749536A1/fr not_active Withdrawn
-
2006
- 2006-08-02 CA CA2617534A patent/CA2617534C/fr not_active Expired - Fee Related
- 2006-08-02 PL PL06776572T patent/PL1917026T3/pl unknown
- 2006-08-02 CN CN2006800369202A patent/CN101291686B/zh not_active Expired - Fee Related
- 2006-08-02 WO PCT/EP2006/007660 patent/WO2007014771A1/fr active Application Filing
- 2006-08-02 EP EP06776572.7A patent/EP1917026B9/fr not_active Not-in-force
- 2006-08-02 DK DK06776572.7T patent/DK1917026T3/da active
- 2006-08-02 KR KR1020087005187A patent/KR101362993B1/ko active IP Right Grant
- 2006-08-02 EP EP06776573A patent/EP1915175A2/fr not_active Withdrawn
- 2006-08-02 JP JP2008524437A patent/JP2009503009A/ja not_active Withdrawn
- 2006-08-02 WO PCT/EP2006/007661 patent/WO2007014772A2/fr active Application Filing
- 2006-08-02 AU AU2006274979A patent/AU2006274979B2/en not_active Ceased
- 2006-08-02 ES ES06776572.7T patent/ES2468225T3/es active Active
- 2006-08-02 JP JP2008524436A patent/JP5268638B2/ja not_active Expired - Fee Related
- 2006-08-02 BR BRPI0616535A patent/BRPI0616535B8/pt not_active IP Right Cessation
- 2006-08-03 TW TW095128519A patent/TWI441645B/zh not_active IP Right Cessation
- 2006-08-03 TW TW095128520A patent/TW200744633A/zh unknown
-
2008
- 2008-10-21 HK HK08111596.7A patent/HK1119569A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2006274979A1 (en) | 2007-02-08 |
WO2007014772A3 (fr) | 2007-04-12 |
JP5268638B2 (ja) | 2013-08-21 |
BRPI0616535A2 (pt) | 2011-06-21 |
EP1917026B1 (fr) | 2014-03-05 |
EP1749536A1 (fr) | 2007-02-07 |
WO2007014772A2 (fr) | 2007-02-08 |
DK1917026T3 (da) | 2014-06-10 |
CN101291686A (zh) | 2008-10-22 |
EP1917026A1 (fr) | 2008-05-07 |
PL1917026T3 (pl) | 2014-08-29 |
TW200744628A (en) | 2007-12-16 |
CA2617534A1 (fr) | 2007-02-08 |
TW200744633A (en) | 2007-12-16 |
JP2009503008A (ja) | 2009-01-29 |
BRPI0616535B1 (pt) | 2019-11-12 |
WO2007014771A1 (fr) | 2007-02-08 |
ES2468225T9 (es) | 2014-10-24 |
JP2009503009A (ja) | 2009-01-29 |
CN101291686B (zh) | 2013-03-13 |
EP1917026B9 (fr) | 2014-06-18 |
KR20080043324A (ko) | 2008-05-16 |
TWI441645B (zh) | 2014-06-21 |
EP1915175A2 (fr) | 2008-04-30 |
KR101362993B1 (ko) | 2014-02-21 |
ES2468225T3 (es) | 2014-06-16 |
BRPI0616535B8 (pt) | 2021-05-25 |
CA2617534C (fr) | 2016-07-05 |
AU2006274979B2 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI366469B (en) | Emulsified skin agent for external use | |
ZA200708438B (en) | External preparation for skin | |
HK1122991A1 (en) | External preparation for skin | |
GB0518769D0 (en) | Topical formulations | |
HK1115328A1 (en) | Composition for treating skin lesions | |
GB2451597B (en) | Compositions for topical treatment | |
EP1938808A4 (fr) | Préparation à usage externe. | |
HK1119569A1 (en) | Lipidated tissue factor for use as topical antihemorrhagic agent | |
EP1854354A4 (fr) | Agent destine a ameliorer un pouvoir antiseptique | |
GB2416693B (en) | Composition for reducing blood lipids | |
EP1957080A4 (fr) | Formulations de glucocorticosteroide locales | |
EP1895843A4 (fr) | Formules topiques de micogel | |
ZA200605597B (en) | Compositions for use with skin | |
GB0516610D0 (en) | Compounds for use in therapy | |
ZA201003835B (en) | Therapeutic agent for ulcer | |
AU3435P (en) | Kakegawa S63 Calibrachoa hybrid | |
AU3279P (en) | USCALI11 Calibrachoa hybrid | |
AU3234P (en) | Balcabcher Calibrachoa hybrid | |
AU3233P (en) | Balcabpurp Calibrachoa hybrid | |
AU3280P (en) | USCALI4 Calibrachoa hybrid | |
AU3236P (en) | Balcabrose Calibrachoa hybrid | |
AU3281P (en) | USCALI28 Calibrachoa hybrid | |
AU3235P (en) | Balcabwite Calibrachoa hybrid | |
AU3238P (en) | Balcabred Calibrachoa hybrid | |
GB0517519D0 (en) | Topical prostaglandin formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210807 |